AIMS: To investigate the association between early cannabis use and subclinical psychotic experiences, distinguishing between five levels of use: never used, discontinued use (life-time users who did not use in the preceding year), experimental use, regular use and heavy use. DESIGN: Cross-sectional observational study. SETTING: Dutch Health Behaviour in School-aged Children (HBSC) study, 2005 wave. PARTICIPANTS: A total of 4552 secondary school children aged 12-16 years. MEASUREMENTS: Cannabis use, Community Assessment of Psychic Experiences (CAPE) positive scale, confounding factors: age, gender, family affluence, household composition, social support, alcohol use, cigarette smoking, ethnicity and urbanicity. FINDINGS: The association between cannabis use and subclinical positive symptoms was confirmed, and remained significant after extensive adjustment for potential confounders. Associations were found for all user groups, with strongest associations for the discontinued use group (β = 0.061, P = 0.000) and for the heavy use group (β = 0.065, P = 0.000). CONCLUSIONS: There is an enduring association between cannabis use at an early age and subclinical positive psychotic experiences, even after abstaining from cannabis for at least 1 year.
AIMS: To investigate the association between early cannabis use and subclinical psychotic experiences, distinguishing between five levels of use: never used, discontinued use (life-time users who did not use in the preceding year), experimental use, regular use and heavy use. DESIGN: Cross-sectional observational study. SETTING: Dutch Health Behaviour in School-aged Children (HBSC) study, 2005 wave. PARTICIPANTS: A total of 4552 secondary school children aged 12-16 years. MEASUREMENTS: Cannabis use, Community Assessment of Psychic Experiences (CAPE) positive scale, confounding factors: age, gender, family affluence, household composition, social support, alcohol use, cigarette smoking, ethnicity and urbanicity. FINDINGS: The association between cannabis use and subclinical positive symptoms was confirmed, and remained significant after extensive adjustment for potential confounders. Associations were found for all user groups, with strongest associations for the discontinued use group (β = 0.061, P = 0.000) and for the heavy use group (β = 0.065, P = 0.000). CONCLUSIONS: There is an enduring association between cannabis use at an early age and subclinical positive psychotic experiences, even after abstaining from cannabis for at least 1 year.
Authors: Nicole R Karcher; Deanna M Barch; Catherine H Demers; David A A Baranger; Andrew C Heath; Michael T Lynskey; Arpana Agrawal Journal: JAMA Psychiatry Date: 2019-01-01 Impact factor: 21.596
Authors: Nora Penzel; Linda A Antonucci; Linda T Betz; Rachele Sanfelici; Johanna Weiske; Oliver Pogarell; Paul Cumming; Boris B Quednow; Oliver Howes; Peter Falkai; Rachel Upthegrove; Alessandro Bertolino; Stefan Borgwardt; Paolo Brambilla; Rebekka Lencer; Eva Meisenzahl; Marlene Rosen; Theresa Haidl; Lana Kambeitz-Ilankovic; Stephan Ruhrmann; Raimo R K Salokangas; Christos Pantelis; Stephen J Wood; Nikolaos Koutsouleris; Joseph Kambeitz Journal: Neuropsychopharmacology Date: 2021-03-03 Impact factor: 7.853
Authors: Sukanta Saha; James G Scott; Daniel Varghese; Louisa Degenhardt; Tim Slade; John J McGrath Journal: BMC Psychiatry Date: 2011-12-28 Impact factor: 3.630
Authors: Marco Colizzi; Nathalie Weltens; Philip McGuire; David Lythgoe; Steve Williams; Lukas Van Oudenhove; Sagnik Bhattacharyya Journal: Mol Psychiatry Date: 2019-02-15 Impact factor: 15.992
Authors: Sania Shakoor; Helena M S Zavos; Philip McGuire; Alastair G Cardno; Daniel Freeman; Angelica Ronald Journal: Psychiatry Res Date: 2015-04-14 Impact factor: 3.222